Creatine ester anti-inflammatory compounds and formulations
申请人:——
公开号:US20030212130A1
公开(公告)日:2003-11-13
The present invention provides a creatine ester anti-inflammatory compound which may be received by animals and then metabolized into a biologically active form of creatine. The biologically active creatine inhibits the production of chemical mediators, released during an inflammatory response, which are important components in the inflammatory response and the inflammation and pain resulting from physical or chemical trauma to cells and tissue.
Creatine ester pronutrient compounds and formulations
申请人:Board of Regents of
the University of Nebraska
公开号:EP1688139A1
公开(公告)日:2006-08-09
The present invention describes a method for providing creatine to an animal which includes receiving a creatine ester by the animal. The creatine ester is suitable for being modified by the animal to form creatine.
CREATINE ESTER PRONUTRIENT COMPOUNDS AND FORMULATIONS
申请人:Board of Regents ofthe University of Nebraska
公开号:EP1324760A1
公开(公告)日:2003-07-09
EP1324760A4
申请人:——
公开号:EP1324760A4
公开(公告)日:2005-08-10
CREATINE ESTER ANTI-INFLAMMATORY COMPOUNDS AND FORMULATIONS
申请人:Miller Donald W.
公开号:US20090137669A1
公开(公告)日:2009-05-28
The present invention provides a creatine ester anti-inflammatory compound which may be received by animals and then metabolized into a biologically active form of creatine. The biologically active creatine inhibits the production of chemical mediators, released during an inflammatory response, which are important components in the inflammatory response and the inflammation and pain resulting from physical or chemical trauma to cells and tissue.